Home » Packaging » Biopharmaceutical Contract Manufacturing Market

Biopharmaceutical Contract Manufacturing Market By Source (Mammalian, Non-mammalian)By Service (Process Development, Downstream., Upstream, Fill & Finish Operations, Analytical & QC studies, Packaging)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Market Insights

The global demand for biopharmaceutical contract manufacturing was valued at USD 8.8 Billion in 2022 and is expected to reach USD 17.9 Billion in 2030, growing at a CAGR of 9.5% between 2023 and 2030.
The mammalian is the market leader in the source and holds over 70% of the market’s value in 2022, while the non-mammalian is anticipated to show the quickest CAGR over the forecast period,
The Upstream segment governs the global demand for biopharmaceutical contract manufacturing, holding a massive share of over 30% in 2022, and is expected to grow at a rapid CAGR.
Biologics is the market leader in products, holding over 30% of the market’s value in 2022.
The infectious diseases segment governs the global demand for biopharmaceutical contract manufacturing, holding a massive share of over 40% in 2022, and is expected to grow at a rapid CAGR.
North America is fueling the growth of the biopharmaceutical contract manufacturing industry with over one-third share in 2022. Asia Pacific and Europe collectively accounted for just under 40% share in 2022. Europe held over 22% share in 2022.
Due to its well-established biopharmaceutical industry, robust regulatory environment, technical breakthroughs, and high demand for biologics, North America now dominates the biopharmaceutical contract manufacturing market.
The rising demand for personalized medicine and targeted therapeutics, which call for specific manufacturing capabilities and knowledge, drives the biopharmaceutical contract manufacturing industry. The complicated and changing regulatory environment, which makes it difficult for contract manufacturing businesses to ensure compliance and navigate the legal requirements of various areas and nations, is a market restraint.

Key Highlights of the Report

The global biopharmaceutical contract manufacturing market is segmented by source, service, product, therapeutic area, and region. Mammalian category is the most widely used, while upstream category is a widely utilized segment. Biologics category is the most commonly used, while infectious diseases are a widely utilized segment. North America is leading the market growth.

Two factors are driving the market for biopharmaceutical contract manufacturing, the rising need for customized treatment and the expanding pipeline of biologics. The complicated regulatory landscape and strict quality standards, which can be difficult for manufacturers, are market barriers.

Nonetheless, the global biopharmaceutical contract manufacturing market is expected to grow due to the patent expirations of biologic drugs and the market for biosimilars. Additionally, pharmaceutical companies are increasingly outsourcing to take advantage of specialized knowledge and cut costs in manufacturing processes.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Overview

The global biopharmaceutical contract manufacturing market has grown steadily in recent years. It is expected to grow at a CAGR of 9.5% between 2023 and 2030. The market was valued at USD 8.8 Billion in 2022 and is expected to reach USD 17.9 Billion in 2030.

What Are The Main Drivers Of The Global Biopharmaceutical Contract Manufacturing Market?

Due to their success in treating various ailments, biologics, including monoclonal antibodies and recombinant proteins, are seeing tremendous growth in demand. Due to this, contract manufacturing services are necessary to satisfy the production needs of biopharmaceutical enterprises.

What Are The Major Challenges Faced By The Global Biopharmaceutical Contract Manufacturing Market?

The biopharmaceutical sector is subject to severe regulatory scrutiny and very high compliance criteria. Contract manufacturing companies (CMOs) may find it difficult to adhere to these rules and maintain constant quality throughout manufacturing.

What Are The Growth Opportunities In The Global Biopharmaceutical Contract Manufacturing Market?

Opportunities for biosimilar medicine producers have arisen due to biologic medication patent expirations. Contract manufacturing companies can profit from this expanding industry by offering knowledge in the creation of biosimilars and assisting pharmaceutical companies in bringing affordable substitutes to the market.

Executive Summary

Overview of the Global Biopharmaceutical Contract Manufacturing Market

Due to the rising demand for biologics, the cost benefits of outsourcing, and the growing market for biosimilars, the global biopharmaceutical contract manufacturing market is expanding significantly. The market faces difficulties like strict regulatory requirements, capacity limitations, and concerns about intellectual property protection. However, the increasing demand for biosimilars, growing markets, cutting-edge medicines, outsourcing tendencies, and technical improvements offer potential opportunities. Contract manufacturing businesses play a significant role in supporting the manufacture and research of biopharmaceuticals, adapting to the changing demands of pharmaceutical companies worldwide. These organizations are required to have specialized expertise, operational efficiency, and cost-effectiveness.

Market Definition

Biopharmaceutical contract manufacturing is the practice of biopharmaceutical businesses outsourcing their manufacturing operations and services to specialist contract manufacturing organizations (CMOs). To handle the manufacture of biopharmaceutical goods, such as biologics, monoclonal antibodies, recombinant proteins, vaccines, and other cutting-edge medicines, these CMOs have the requisite infrastructure, facilities, and experience. Process development, upstream and downstream processing, fill and finish operations, analytical and quality control studies, and packaging are a few of the activities involved in biopharmaceutical contract manufacturing. Pharmaceutical businesses and CMOs work together to ensure effective and legal manufacturing compliance with high regulatory standards. Biopharmaceutical firms can focus on core competencies like research and development while lowering costs, risks, and time-to-market for their products by outsourcing manufacturing processes to CMOs, which can leverage the knowledge, resources, and operational efficiency of specialized partners.

Segmentation by Source

The mammalian is the leading segment by source, holding over 70% share in value in 2022.
The non-mammaliansegment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Service

The upstream segment governs the global demand for biopharmaceutical contract manufacturing, holding a massive share of over 30% in 2022, and is also expected to grow at a rapid CAGR.
Downstream contributes to the rest of the demand for biopharmaceutical contract manufacturing.

Segmentation by Product

Biologics product is the leading segment by product and held over 30% share in value in 2022.
The monoclonal antibodies (MABs) segment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Therapeutic Area

The infectious diseases segment governs the global demand for biopharmaceutical contract manufacturing, holding a massive share of over 40% in 2022, and is also expected to grow at a rapid CAGR.
Cardiovascular diseases contribute to the rest of the demand for biopharmaceutical contract manufacturing.

Segmentation by Region

North America is fueling the growth of the biopharmaceutical contract manufacturing industry with over one-third share in 2022.
Asia Pacific and Europe collectively account for just under 40% share in 2022, with Europe holding over 22% share in the same year.
The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for biopharmaceutical contract manufacturing.

The increasing number of biologics under research and their expanding significance in treating various diseases are two factors driving the market for biopharmaceutical contract manufacturing. Because biologics have benefits like better specificity and efficacy, contract manufacturing services are in high demand to meet the production demands of biopharmaceutical companies.

Due to the country’s thriving biopharmaceutical industry and many pharmaceutical businesses, the biopharmaceutical contract manufacturing market is heavily utilized in the United States. The market plays a crucial role in pharmaceutical product research and production ecology. Biologics, monoclonal antibodies, and other cutting-edge medicines are produced with the help of contract manufacturing companies (CMOs). CMOs assist pharmaceutical businesses in streamlining manufacturing processes, lowering costs, and accelerating time-to-market for their products because of their specialized knowledge and cutting-edge facilities. The demand for flexible capacity, accessibility to cutting-edge technologies, and the capacity to adhere to stringent regulatory standards influence how well the market is utilized in the United States.

Germany has a significant position in the European pharmaceutical business, reflected in the country’s considerable use of biopharmaceutical contract manufacturing. The market is a major force behind the creation of biologics, vaccines, and other cutting-edge treatments. The services contract manufacturing companies (CMOs) in Germany provide include process development, analytical investigations, and fill and finish operations. Several factors influence market utilization, including the nation’s sophisticated healthcare system, robust regulatory environment, and skilled labor. To ensure effective production, quality compliance, and prompt delivery of biopharmaceutical goods to local and international markets, German CMOs work closely with pharmaceutical companies. The German market’s use plays a vital role in developing and innovating the nation’s biopharmaceutical sector.

Two factors are driving the market for biopharmaceutical contract manufacturing, the rise in the number of biologics being researched and their growing importance in treating various ailments. Contract manufacturing services are highly sought after to suit the production needs of biopharmaceutical companies since biologics have advantages, including greater specificity and efficacy.

Increasing Demand for Personalized Medicine

The rising need for personalized medication is significantly driving the market for biopharmaceutical contract manufacturing. Targeted treatments based on a person’s genetic profile, disease characteristics, and response patterns are the goal of personalized medicine. This strategy has the potential to lead to better therapeutic results and fewer side effects.

There is a rising demand for specialized manufacturing capabilities to create individualized medicines. To develop individualized medications at scale, biopharmaceutical contract manufacturing organizations (CMOs) are essential to addressing this demand because they offer the necessary infrastructure, knowledge, and flexibility.

Expansion of the Biosimilars Market

Another important factor driving the biopharmaceutical contract manufacturing market is the biosimilars industry’s growth. Biosimilars are extremely similar variants of licensed biologic medications comparable in quality, efficacy, and safety. They provide patients with improved accessibility and may save healthcare expenses by offering affordable replacements for pricy biologics.

The market for biosimilars is expanding as biological medicine patents expire. The competence of contract manufacturing companies (CMOs) in biosimilars’ research, production, and regulatory compliance is crucial to this expansion.

CMOs work with pharmaceutical companies to create and optimize manufacturing methods for biosimilars to ensure consistent quality and comparability to the reference biologics. They offer specialized machinery, facilities, and technical know-how to satisfy the exacting regulatory specifications and high-quality standards related to the production of biosimilars.

Complex And Evolving Regulatory Landscape

The complicated and dynamic regulatory environment is one barrier to the market for contract manufacture of biopharmaceuticals. To guarantee patient safety and high-quality products, the biopharmaceutical business is subject to strict regulatory scrutiny. For contract manufacturing organizations (CMOs), managing the intricate and constantly changing regulatory requirements can be difficult.

The legislation of the many regions and nations where their clients do business must be updated, which can take time and resources. It is more difficult to comply with the strict compliance standards and ensure that regulatory requirements are followed consistently throughout the production process, which can slow down business operations and increase expenses for CMOs and their clients.

Growth of the Biosimilars Market

The expansion of the biosimilars industry represents a huge opportunity in the biopharmaceutical contract manufacturing sector. Biosimilars offer affordable options to costly biologics and are similar copies of licensed biologic medications. Contract manufacturing companies (CMOs) have a profitable chance to diversify their offerings as the biologics market’s patents begin to lapse.

By giving their skills in biosimilar development, process improvement, and manufacturing, CMOs can take advantage of this chance. They work together with pharmaceutical companies to guarantee the quality and comparability of biosimilars to reference biologics. CMOs can use their specialized infrastructure, technical know-how, and regulatory compliance abilities to mass-produce biosimilars.

Emerging Markets and Outsourcing Trends

Emerging markets and the outsourcing trend present another business potential in biopharmaceutical contract manufacturing. Emerging markets have enormous development potential for contract manufacturing companies, particularly in Asia Pacific and Latin America.

Lower production costs, a competent workforce, and improved regulatory frameworks are just a few benefits these markets provide. CMOs can set up shops in these areas and use their knowledge to assist regional pharmaceutical firms in producing biopharmaceutical goods. CMOs can meet the demand for high-quality, cost-effective manufacturing services.

Additionally, the continued outsourcing trend among pharmaceutical businesses offers CMOs a chance to increase their clientele and sources of income. Pharmaceutical businesses are increasingly outsourcing manufacturing activities to CMOs to get access to specialized knowledge, cut costs, and reduce risks. Pharmaceutical businesses can concentrate on their key strengths, such as research and development, by outsourcing their contract manufacturing to CMOs, who can present themselves as trustworthy partners by providing end-to-end solutions.

Competitive Landscape

Key Players

The global biopharmaceutical contract manufacturing market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Boehringer Ingelheim GmbH
Lonza
Inno Biologics Sdn Bhd
Rentschler Biotechnologie GmbH
JRS Pharma
AGC Biologics
ProBioGen
Fujifilm Diosynth Biotechnologies U.S.A., Inc.
Toyobo Co., Ltd.
Samsung BioLogics
Thermo Fisher Scientific, Inc.
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc
Novartis AG
ADMA Biologics, Inc.
Catalent, Inc
Cambrex Corporation
Pfizer Inc.
Siegfried Holding AG

The presence of numerous well-established contract manufacturing organizations (CMOs) vying for market share defines the competitive landscape of the biopharmaceutical contract manufacturing business. These CMOs set themselves apart through their production skills, regulatory compliance, technological know-how, global reach, and history of providing pharmaceutical clients with high-quality and reasonably priced solutions. The market is competitive, with international businesses and local CMOs seeking deals and alliances with biopharmaceutical firms worldwide.

September 2022 marks the signing of a contract by Shuttle Pharmaceuticals Holdings Inc. and TCG GreenChem, Inc. for the production of Ropidoxuridine, the company’s principal clinical sensitizer drug candidate, for use in creating the drug product for testing in Ropidoxuridine and RT of malignancies clinical studies.

In January 2022, INCOG BioPharma Services, a contract development and manufacturing organization (CDMO) located in Indiana that specializes in sterile injectables, announced that the building of its production facility and global headquarters in Fishers is almost finished.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

The non-mammalian is predicted to exhibit the fastest CAGR over the forecast period, while the mammalian is the market leader in the source and owns over 70% of the market’s value in 2022.
The Upstream segment, predicted to develop at a high CAGR, will dominate the global demand for biopharmaceutical contract manufacturing, controlling a sizeable share of over 30% in 2022.
Biologics is the product market leader, accounting for over 30% of the industry’s value in 2022.
The infectious diseases market is predicted to dominate the global demand for biopharmaceutical contract manufacturing in 2022, accounting for a sizeable proportion of over 40% of the market.
With a share of more than one-third in 2022, North America is the industry’s primary growth driver. Asia Pacific and Europe made up slightly under 40% of the market in 2022. In 2022, Europe owned a share of over 22%.

Future Outlook

The market for contract production of biopharmaceuticals has enormous future potential.
The market is anticipated to increase due to elements like rising demand for biologics, customized medicine, biosimilars, technological improvements, and emerging markets.
The industry is primed for growth as pharmaceutical companies outsource production activities to specialist contract manufacturing organizations (CMOs).
Future research and production of biopharmaceutical products will rely heavily on CMOs that can provide sophisticated manufacturing skills, regulatory compliance expertise, and effective production procedures. These CMOs will be well-positioned to capitalize on the expanding demand.

Segmentation

By Source
- Mammalian
- Non-mammalian
By Service
- Process Development
- Downstream
- Upstream
- Fill & Finish Operations
- Analytical & QC studies
- Packaging
By Product
- Biologics
- Monoclonal antibodies (MABs)
- Recombinant Proteins
- Vaccines
- Antisense, RNAi, & Molecular Therapy
- Others
- Biosimilars
By Therapeutic Area
- Oncology
- Autoimmune Diseases
- Metabolic Diseases
- Cardiovascular Diseases
- Neurology
- Infectious Diseases
- Others
By Region

North America
- USA
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Biological Bone Repair Materials Market
2.2. Global Biological Bone Repair Materials Market, By Type
2.3. Global Biological Bone Repair Materials Market, By Distribution Channel
2.4. Global Biological Bone Repair Materials Market, By Application
2.5. Global Biological Bone Repair Materials Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Biological Bone Repair Materials Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Distribution Channel
3.5.3. Application
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Biological Bone Repair Materials Market, By Type
7.1. Global Biological Bone Repair Materials Market Overview, by Type
7.1.1. Global Biological Bone Repair Materials Market Revenue Share, By Type, 2022 Vs 2030 (in %)
7.2. Bone Growth Stimulators (BGS)
7.2.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
7.3. Viscosupplements
7.3.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
7.4. Bone Graft Substitute
7.4.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)

8. Global Biological Bone Repair Materials Market, By Distribution Channel
8.1. Global Biological Bone Repair Materials Market Overview, by Distribution Channel
8.1.1. Global Biological Bone Repair Materials Market, By Distribution Channel, 2022 vs 2030 (in %)
8.2. Direct Sales
8.2.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
8.3. Retail Pharmacies
8.3.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
8.4. Online Pharmacies
8.4.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)

9. Global Biological Bone Repair Materials Market, by Application, 2017-2030 (US$ Bn)
9.1. Global Biological Bone Repair Materials Market Overview, by Application
9.1.1. Global Biological Bone Repair Materials Market, By Application, 2022 vs 2030 (in%)
9.2. Hospitals
9.2.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
9.3. Ambulatory Surgical Centres
9.3.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
9.4. Research & Academic Institutions
9.4.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
9.5. Orthopaedics Clinics
9.5.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)
9.6. Specialty Clinics
9.6.1. Global Biological Bone Repair Materials Market, By Region, 2017-2030 (US$ Bn)

10. Global Biological Bone Repair Materials Market, By Region
10.1. Global Biological Bone Repair Materials Market Overview, by Region
10.1.1. Global Biological Bone Repair Materials Market, By Region, 2022 vs 2030 (in%)
10.2. Type
10.2.1. Global Biological Bone Repair Materials Market, By Type, 2017-2030 (US$ Bn)
10.3. Distribution Channel
10.3.1. Global Biological Bone Repair Materials Market, By Distribution Channel, 2017-2030 (US$ Bn)
10.4. Application
10.4.1. Global Biological Bone Repair Materials Market, By Application, 2017-2030 (US$ Bn)

11. North America Biological Bone Repair Materials Market Analysis
11.1. North America Biological Bone Repair Materials Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. North America Biological Bone Repair Materials Market, by Distribution Channel, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. North America Biological Bone Repair Materials Market, by Application, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. North America Biological Bone Repair Materials Market, by Country, 2017-2030 (US$ Bn)
11.4.1. North America Biological Bone Repair Materials Market, by Country, 2022 Vs 2030 (in%)
11.4.2. U.S.
11.4.2.1. U.S. Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. U.S. Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
11.4.2.3. U.S. Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.2.4. U.S. Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
11.4.3. Canada
11.4.3.1. Canada Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Canada Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
11.4.3.3. Canada Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.3.4. Canada Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
11.4.4. Mexico
11.4.4.1. Mexico Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.4.2. Mexico Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
11.4.4.3. Mexico Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.4.4. Mexico Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)

12. Europe Biological Bone Repair Materials Market Analysis
12.1. Europe Biological Bone Repair Materials Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Europe Biological Bone Repair Materials Market, by Distribution Channel, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Europe Biological Bone Repair Materials Market, by Application, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Europe Biological Bone Repair Materials Market, by Country, 2017-2030 (US$ Bn)
12.4.1. Europe Biological Bone Repair Materials Market, by Country, 2022 Vs 2030 (in%)
12.4.2. Germany
12.4.2.1. Germany Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. Germany Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.2.3. Germany Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.2.4. Germany Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
12.4.3. France
12.4.3.1. France Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. France Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.3.3. France Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.3.4. France Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
12.4.4. UK
12.4.4.1. UK Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.4.2. UK Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.4.3. UK Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.4.4. UK Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
12.4.5. Italy
12.4.5.1. Italy Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.5.2. Italy Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.5.3. Italy Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.5.4. Italy Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
12.4.6. Spain
12.4.6.1. Spain Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.6.2. Spain Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.6.3. Spain Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.6.4. Spain Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
12.4.7. Rest of Europe
12.4.7.1. Rest of Europe Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.7.2. Rest of Europe Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
12.4.7.3. Rest of Europe Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.7.4. Rest of Europe Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)

13. Asia Pacific Biological Bone Repair Materials Market Analysis
13.1. Asia Pacific Biological Bone Repair Materials Market, by Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Asia Pacific Biological Bone Repair Materials Market, by Distribution Channel, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Asia Pacific Biological Bone Repair Materials Market, by Application, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Asia Pacific Biological Bone Repair Materials Market, by Country, 2017-2030 (US$ Bn)
13.4.1. Asia Pacific Biological Bone Repair Materials Market, by Country, 2022 Vs 2030 (in%)
13.4.2. China
13.4.2.1. China Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.2.2. China Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.2.3. China Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.2.4. China Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
13.4.3. Japan
13.4.3.1. Japan Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.3.2. Japan Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.3.3. Japan Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.3.4. Japan Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
13.4.4. India
13.4.4.1. India Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.4.2. India Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.4.3. India Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.4.4. India Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
13.4.5. South Korea
13.4.5.1. South Korea Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.5.2. South Korea Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.5.3. South Korea Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.5.4. South Korea Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
13.4.6. South-East Asia
13.4.6.1. South-East Asia Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.6.2. South-East Asia Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.6.3. South-East Asia Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.6.4. South-East Asia Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
13.4.7. Rest of Asia Pacific
13.4.7.1. Rest of Asia Pacific Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.4.7.2. Rest of Asia Pacific Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
13.4.7.3. Rest of Asia Pacific Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
13.4.7.4. Rest of Asia Pacific Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)

14. Latin America Biological Bone Repair Materials Market Analysis
14.1. Latin America Biological Bone Repair Materials Market, by Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Latin America Biological Bone Repair Materials Market, by Distribution Channel, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Latin America Biological Bone Repair Materials Market, by Application, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Latin America Biological Bone Repair Materials Market, by Country, 2017-2030 (US$ Bn)
14.4.1. Latin America Biological Bone Repair Materials Market, by Country, 2022 Vs 2030 (in%)
14.4.2. Brazil
14.4.2.1. Brazil Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.2.2. Brazil Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
14.4.2.3. Brazil Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
14.4.2.4. Brazil Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
14.4.3. Argentina
14.4.3.1. Argentina Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.3.2. Argentina Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
14.4.3.3. Argentina Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
14.4.3.4. Argentina Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
14.4.4. Rest of Latin America
14.4.4.1. Rest of Latin America Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.4.4.2. Rest of Latin America Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
14.4.4.3. Rest of Latin America Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
14.4.4.4. Rest of Latin America Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)

15. Middle East and Africa Biological Bone Repair Materials Market Analysis
15.1. Middle East and Africa Biological Bone Repair Materials Market, by Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Middle East and Africa Biological Bone Repair Materials Market, by Distribution Channel, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Middle East and Africa Biological Bone Repair Materials Market, by Application, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Middle East and Africa Biological Bone Repair Materials Market, by Country, 2017-2030 (US$ Bn)
15.4.1. Middle East and Africa Biological Bone Repair Materials Market, by Country, 2022 Vs 2030 (in%)
15.4.2. GCC Countries
15.4.2.1. GCC Countries Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.2.2. GCC Countries Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
15.4.2.3. GCC Countries Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
15.4.2.4. GCC Countries Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
15.4.3. South Africa
15.4.3.1. South Africa Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.3.2. South Africa Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
15.4.3.3. South Africa Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
15.4.3.4. South Africa Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)
15.4.4. Rest of Middle East and Africa
15.4.4.1. Rest of Middle East and Africa Biological Bone Repair Materials Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.4.4.2. Rest of Middle East and Africa Biological Bone Repair Materials, By Type, 2017-2030 (US$ Bn)
15.4.4.3. Rest of Middle East and Africa Biological Bone Repair Materials, By Distribution Channel, 2017-2030 (US$ Bn)
15.4.4.4. Rest of Middle East and Africa Biological Bone Repair Materials, By Application, 2017-2030 (US$ Bn)

16. Company Profiles
16.1. Medtronic Plc
16.1.1. Company Overview
16.1.2. Products/Services Portfolio
16.1.3. Geographical Presence
16.1.4. Financial Summary
16.1.4.1. Market Revenue and Net Profit (2019-2022)
16.1.4.2. Business Segment Revenue Analysis
16.1.4.3. Geographical Revenue Analysis
16.2. NuVasive Inc
16.3. Stryker Corporation
16.4. Zimmer Biomet Holdings
16.5. Orthofix International N.V.
16.6. Anika Therapeutics Inc
16.7. DePuy Synthes (Johnson & Johnson)
16.8. Bioventus
16.9. Arthrex Inc
16.10. SeaSpine Holdings Corporation
16.11. Sanofi S.A.
16.12. DJO Global Inc
16.13. Seikagaku Corporation
16.14. RTI Surgical Inc
16.15. Heraeus Holding GmbH
16.16. Fidia Pharma USA Inc
16.17. TRB Chemedica International SA
16.18. AlloSource
16.19. Musculoskeletal Transplant Foundation Inc
16.20. ITO Co. Ltd

List of Figures
FIG. 1 Global Biological Bone Repair Materials Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biological Bone Repair Materials Market Segmentation
FIG. 4 Global Biological Bone Repair Materials Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Biological Bone Repair Materials Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 6 Global Biological Bone Repair Materials Market, by Application, 2022 (US$ Bn)
FIG. 7 Global Biological Bone Repair Materials Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2022
FIG. 9 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 10 Attractive Investment Proposition, by Application, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Biological Bone Repair Materials Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Biological Bone Repair Materials Market Manufacturers, 2022
FIG. 14 Global Biological Bone Repair Materials Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 15 Global Biological Bone Repair Materials Market, by Bone Growth Stimulators (BGS), Value, 2017-2030 (US$ Bn)
FIG. 16 Global Biological Bone Repair Materials Market, by Viscosupplements, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Biological Bone Repair Materials Market, by Bone Graft Substitute, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Biological Bone Repair Materials Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Biological Bone Repair Materials Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 20 Global Biological Bone Repair Materials Market, by Direct Sales, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Biological Bone Repair Materials Market, by Retail Pharmacies, 2017-2030 (US$ Bn)
FIG. 22 Global Biological Bone Repair Materials Market, by Online Pharmacies, 2017-2030 (US$ Bn)
FIG. 23 Global Biological Bone Repair Materials Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 24 Global Biological Bone Repair Materials Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Biological Bone Repair Materials Market, by Ambulatory Surgical Centres, 2017-2030 (US$ Bn)
FIG. 26 Global Biological Bone Repair Materials Market, by Orthopaedics Clinics, 2017-2030 (US$ Bn)
FIG. 27 Global Biological Bone Repair Materials Market, by Specialty Clinics, 2017-2030 (US$ Bn)
FIG. 28 Global Biological Bone Repair Materials Market, by Research & Academic Institutions, 2017-2030 (US$ Bn)
FIG. 29 North America Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 30 U.S. Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 31 Canada Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 32 Europe Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 33 Germany Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 34 France Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 35 U.K. Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 36 Italy Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 37 Spain Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Europe Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 39 Asia Pacific Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 40 China Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 41 Japan Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 42 India Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 43 South Korea Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 44 South-East Asia Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Asia Pacific Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 46 Latin America Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 47 Brazil Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Latin America Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 50 Middle East & Africa Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 51 GCC Countries Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 52 South Africa Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Biological Bone Repair Materials Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Biological Bone Repair Materials Market
TABLE 2 Global Biological Bone Repair Materials Market: Market Drivers Impact Analysis
TABLE 3 Global Biological Bone Repair Materials Market: Market Restraints Impact Analysis
TABLE 4 Global Biological Bone Repair Materials Market, by Competitive Benchmarking, 2022
TABLE 5 Global Biological Bone Repair Materials Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Biological Bone Repair Materials Market, by Key Strategies Analysis, 2022
TABLE 7 Global Biological Bone Repair Materials Market, by Bone Growth Stimulators (BGS), By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Biological Bone Repair Materials Market, by Bone Growth Stimulators (BGS), By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Biological Bone Repair Materials Market, by Viscosupplements, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Biological Bone Repair Materials Market, by Viscosupplements, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Biological Bone Repair Materials Market, by Bone Graft Substitute, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Biological Bone Repair Materials Market, by Bone Graft Substitute, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Biological Bone Repair Materials Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Biological Bone Repair Materials Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Biological Bone Repair Materials Market, by Direct Sales, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Biological Bone Repair Materials Market, by Direct Sales, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Biological Bone Repair Materials Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Biological Bone Repair Materials Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Biological Bone Repair Materials Market, by Online Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Biological Bone Repair Materials Market, by Online Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Biological Bone Repair Materials Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Biological Bone Repair Materials Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Biological Bone Repair Materials Market, by Ambulatory Surgical Centres, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Biological Bone Repair Materials Market, by Ambulatory Surgical Centres, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Biological Bone Repair Materials Market, by Orthopaedics Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Biological Bone Repair Materials Market, by Orthopaedics Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Biological Bone Repair Materials Market, by Specialty Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Biological Bone Repair Materials Market, by Specialty Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Biological Bone Repair Materials Market, by Research & Academic Institutions, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Biological Bone Repair Materials Market, by Research & Academic Institutions, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 32 Global Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 33 Global Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 34 Global Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 35 Global Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 36 Global Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 37 Global Biological Bone Repair Materials Market, by Region, 2017-2022 (US$ Bn)
TABLE 38 Global Biological Bone Repair Materials Market, by Region, 2023-2030 (US$ Bn)
TABLE 39 North America Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 40 North America Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 41 North America Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 42 North America Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 43 North America Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 44 North America Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 45 North America Biological Bone Repair Materials Market, by Country, 2017-2022 (US$ Bn)
TABLE 46 North America Biological Bone Repair Materials Market, by Country, 2023-2030 (US$ Bn)
TABLE 47 United States Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 48 United States Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 49 United States Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 50 United States Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 51 United States Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 52 United States Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 53 Canada Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 54 Canada Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 55 Canada Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 56 Canada Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 57 Canada Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 58 Canada Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 59 Mexico Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 60 Mexico Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 61 Mexico Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 62 Mexico Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 63 Mexico Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 64 Mexico Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 65 Europe Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 66 Europe Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 67 Europe Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 68 Europe Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 69 Europe Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 70 Europe Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 71 Europe Biological Bone Repair Materials Market, by Country, 2017-2022 (US$ Bn)
TABLE 72 Europe Biological Bone Repair Materials Market, by Country, 2023-2030 (US$ Bn)
TABLE 73 Germany Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 74 Germany Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 75 Germany Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 76 Germany Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 77 Germany Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 78 Germany Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 79 France Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 80 France Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 81 France Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 82 France Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 83 France Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 84 France Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 85 United Kingdom Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 86 United Kingdom Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 87 United Kingdom Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 88 United Kingdom Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 89 United Kingdom Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 90 United Kingdom Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 91 Italy Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 92 Italy Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 93 Italy Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 94 Italy Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 95 Italy Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 96 Italy Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 97 Spain Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 98 Spain Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 99 Spain Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 100 Spain Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 101 Spain Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 102 Spain Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 103 Rest of Europe Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 104 Rest of Europe Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 105 Rest of Europe Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 106 Rest of Europe Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 107 Rest of Europe Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 108 Rest of Europe Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 109 Asia Pacific Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 110 Asia Pacific Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 111 Asia Pacific Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 112 Asia Pacific Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 113 Asia Pacific Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 114 Asia Pacific Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 115 China Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 116 China Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 117 China Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 118 China Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 119 China Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 120 China Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 121 Japan Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 122 Japan Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 123 Japan Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 124 Japan Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 125 Japan Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 126 Japan Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 127 India Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 128 India Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 129 India Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 130 India Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 131 India Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 132 India Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 133 South Korea Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 134 South Korea Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 135 South Korea Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 136 South Korea Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 137 South Korea Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 138 South Korea Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 139 South-East Asia Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 140 South-East Asia Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 141 South-East Asia Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 142 South-East Asia Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 143 South-East Asia Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 144 South-East Asia Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 145 Rest of Asia Pacific Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 146 Rest of Asia Pacific Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 147 Rest of Asia Pacific Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 148 Rest of Asia Pacific Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 149 Rest of Asia Pacific Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 150 Rest of Asia Pacific Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 151 Latin America Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 152 Latin America Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 153 Latin America Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 154 Latin America Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 155 Latin America Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 156 Latin America Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 157 Brazil Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 158 Brazil Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 159 Brazil Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 160 Brazil Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 161 Brazil Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 162 Brazil Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 163 Argentina Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 164 Argentina Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 165 Argentina Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 166 Argentina Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 167 Argentina Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 168 Argentina Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 169 Rest of Latin America Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 170 Rest of Latin America Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 171 Rest of Latin America Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 172 Rest of Latin America Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 173 Rest of Latin America Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 174 Rest of Latin America Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 175 Middle East and Africa Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 176 Middle East and Africa Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 177 Middle East and Africa Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 178 Middle East and Africa Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 179 Middle East and Africa Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 180 Middle East and Africa Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 181 GCC Countries Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 182 GCC Countries Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 183 GCC Countries Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 184 GCC Countries Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 185 GCC Countries Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 186 GCC Countries Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 187 South Africa Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 188 South Africa Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 189 South Africa Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 190 South Africa Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 191 South Africa Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 192 South Africa Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)
TABLE 193 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Type, 2017-2022 (US$ Bn)
TABLE 194 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Type, 2023-2030 (US$ Bn)
TABLE 195 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 196 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 197 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Application, 2017-2022 (US$ Bn)
TABLE 198 Rest of Middle East and Africa Biological Bone Repair Materials Market, by Application, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global biopharmaceutical contract manufacturing market?

The global biopharmaceutical contract manufacturing market was valued at USD 8.8 Billion in 2022.

What is the expected growth rate of the biopharmaceutical contract manufacturing market between 2023 and 2030?

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 9.5% between 2023 and 2030, reaching USD 17.9 Billion in 2030.

Which segment is leading the market share in terms of sources?

Mammalian is the leading segment by service, holding over 30% share in value in 2022.

Which service segment governs the demand for biopharmaceutical contract manufacturing worldwide?

Upstream governs the global demand for biopharmaceutical contract manufacturing, holding a massive share of over 50% in 2022.

Which product segment governs the demand for biopharmaceutical contract manufacturing worldwide?

The biologics segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the biopharmaceutical contract manufacturing industry?

North America is fueling the growth of the biopharmaceutical contract manufacturing industry, with an over one-third share in 2022.

Who are the major players in the global biopharmaceutical contract manufacturing market?

The top players include Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, JRS Pharma, and AGC Biologics.

What are the major market drivers of the biopharmaceutical contract manufacturing industry?

The major market drivers are increasing demand for biologics and personalized medicine, growth of the biosimilars market, and advancements in technology and manufacturing processes.

What are the major market restraints of the biopharmaceutical contract manufacturing industry?

The major market restraints include stringent and evolving regulatory landscape and complex manufacturing processes and quality control requirements.

What are the major market opportunities of the biopharmaceutical contract manufacturing industry?

Growth of the biosimilars market, emerging and outsourcing trends, and increasing demand for personalized medicine and targeted therapies.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –